A $365,000 grant from the National Institutes of Health will fund a new mass spectrometer for the University of Texas Medical Branch’s Miriam and Emmett McCoy Stem Cells and Diabetes Mass Spectrometry Research Laboratory.
This state-of-the-art instrument will allow the measurement of biomarkers in the blood of patients with diabetes, traumatic brain injury, substance abuse and hepatocellular carcinoma.
These studies will advance the ability to assess predisposition to disease as well as contribute to diagnosis and management in the development of a personalized medicine approach to patient care.
This state-of-the-art instrument will allow the measurement of biomarkers in the blood of patients with diabetes, traumatic brain injury, substance abuse and hepatocellular carcinoma.
These studies will advance the ability to assess predisposition to disease as well as contribute to diagnosis and management in the development of a personalized medicine approach to patient care.
No comments:
Post a Comment